Skip to main content

DiMe Glossary

Blinding / Masking

One or more parties of the clinical trial are kept unaware of the treatment assignment. Patients, investigators, and healthcare providers may all be blinded to the treatment a patient is receiving.

Want to learn more terms?

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today